ANIK — Anika Therapeutics Inc

Stock analysis, trade plans, and proprietary indicators by Trend Edge.

About Anika Therapeutics Inc

Anika Therapeutics, Inc., a joint preservation company, focuses on early intervention orthopedics in the United States, Europe, and internationally. The company offers osteoarthritis (OA) pain management products and services, such as Monovisc and Orthovisc, which are single- and multi-injection, HA viscosupplement products indicated for pain relief from OA conditions, as well as Cingal, a non-opioid, single-injection OA pain management product; … Read full Trend Edge analysis →

Trend Edge Proprietary Indicators

Key Metrics

Current Price$14.81
Market Cap$200M
Float11.3M
Shares Outstanding13.3M
P/E (Forward)36.90
Price/Sales (TTM)1.72
vs. Analyst Target+18.2% to analyst PT
Profit Margin-9.52%
Operating Margin (TTM)-18.53%
Revenue (TTM)$116M
Earnings Growth (YoY)-50.50%
Dividend RateNone
Analyst Target Price$17.50 (3 analysts)

Financial History

Annual Revenue & Earnings History

YearRevenueNet IncomeGross ProfitEBITDA
2020 $130M -$24.0M $69.0M -$1.0M
2021 $148M $4.1M $82.9M -$4.2M
2022 $156M -$14.9M $93.6M -$4.9M
2023 $121M -$82.7M $82.5M $15.1M
2024 $120M -$56.4M $76.0M $3.0M
2025 $113M -$10.9M $63.8M -$5.3M

Recent Quarterly Revenue & Net Income

QuarterRevenueNet Income
Jun 2025 $28.2M -$4.0M
Sep 2025 $27.8M -$2.3M
Dec 2025 $30.6M $292,000
Mar 2026 $29.6M -$5.1M

Ownership & Float

Insider Ownership6.0%
Institutional Ownership94.7%
Short Float4.9%
% of All Funds Holding1.46%
Number of Funds Holding120

Current Moving Averages

Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.

TimeframeSMAValueTrend Context
Weekly10-Week SMA$14.94Near-term / short-term trend
Weekly40-Week SMA$11.34Medium-term trend
Weekly80-Week SMA$12.64Cyclical trend (business cycle)
Weekly200-Week SMA$20.01Secular trend (multi-year)
Monthly10-Month SMA$11.34Near-term monthly trend
Monthly20-Month SMA$12.94Medium-term monthly trend
Monthly40-Month SMA$18.74Secular monthly trend

Volume Shelves — Support & Resistance

Trend Edge identifies volume shelves: price zones where historically elevated trading volume creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.

Price LevelTypeVolume RatioAge
$9.30 support 1.24x 2 months ago
$8.20 support 1.38x 8 months ago
$17.40 resistance 1.29x 13 months ago
$24.60 resistance 1.11x 18 months ago

Historical Earnings Reactions (115 events)

TimeframeAvg ReturnMedianWin RateBestWorst
Gap 0.80% 0.18% 52.17% 27.49% -17.51%
1 Day -0.35% -1.25% 38.26% 28.86% -24.68%
1 Week 0.18% -0.75% 45.22% 38.53% -24.20%
2 Weeks 0.58% -1.84% 41.74% 51.99% -31.59%
1 Month 2.93% 0.89% 51.75% 107.99% -71.22%

Next earnings: July 18, 2026 (50 days away)

Seasonality & Day-of-Week Patterns

Monthly Seasonality

MonthAvg ReturnWin RateSamples
Jan2.3%51.5%33
Feb7.6%57.6%33
Mar-1.1%48.5%33
Apr4.6%54.5%33
May1.0%56.3%32
Jun2.1%42.4%33
Jul2.5%45.5%33
Aug1.6%51.5%33
Sep-0.4%48.5%33
Oct-1.8%48.5%33
Nov-1.2%48.5%33
Dec3.9%48.5%33

Day-of-Week Tendencies

DayAvg ReturnWin RateSamples
Monday -0.04% 45.0% 1563
Tuesday 0.07% 46.5% 1710
Wednesday 0.05% 45.2% 1707
Thursday 0.23% 44.6% 1674
Friday 0.25% 44.8% 1668

Top Institutional Holders

Institutional holder breakdown coming soon.

Total institutional ownership: 94.7%

Insider Transactions — Smart Summary

Total insider ownership: 6.0%

12-Month Insider Activity Summary

Total Filings2
Net Value+$149,880.66
Net Shares Change17,200
% of Float0.2%
C-Suite Filings1
Clusters Detected0

Key Insiders

NameTitleNet ValueFilingsActivity
Griffin Stephen D. President and CEO +$149,880.66 1 1 buy
HENNEMAN JOHN B III +$73,319.5 1 1 buy

Significant Filings

DateInsiderTitleNet ValuePrice After
2026-04-30 Griffin Stephen D. President and CEO +$149,880.66 Transaction at $12.29, now +20.6%
2026-05-04 HENNEMAN JOHN B III +$73,319.5 Transaction at $14.66, now +1.0%

View full insider transaction history on Trend Edge →

AI Consult Analysis

Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Anika Therapeutics Inc (ANIK) powered by Claude Opus — Anthropic's most capable AI model. The analysis covers five layers: technical analysis (near-term, medium-term, cyclical, and secular trend, momentum, volume shelf support and resistance, breakout and breakdown signals), qualitative analysis (business model, competitive moat, sector dynamics), insider sentiment (buy and sell signals from executive and director transactions), share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and fundamental analysis (valuation, revenue growth, profit margin, earnings quality).

AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit, stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward. Whether you are building a long position, initiating a short, or looking for a reversal setup, AI Consult identifies the highest-probability signal from the current trend.

Get the full AI Consult analysis for ANIK on Trend Edge →